For five months, the National Institutes of Health remained publicly silent about an incident that has now resulted in federal charges against two of its own researchers for allegedly smuggling biological material from an active monkeypox outbreak zone into the United States.
According to RedState, the case exploded into public view only after federal prosecutors unsealed a complaint detailing how NIH scientists Vincent Munster and Claude Kwe arrived at Detroit Metro Airport on January 25, flying in from Brazzaville in the Republic of Congo, where monkeypoxnow officially termed mpoxwas actively spreading. Customs and Border Protection officers pulled the pair aside after noticing a large black plastic case, and when questioned, Munster and Kwe reportedly claimed it contained diagnostic and testing equipment, but agents instead discovered 113 vials packed in Styrofoam coolers.
Munster, a Dutch national, headed the Virus Ecology Section at NIHs Rocky Mountain Laboratories in Hamilton, Montana, a high-containment BSL-4 facility that handles some of the worlds most dangerous pathogens, including Ebola, plague, and Crimean-Congo hemorrhagic fever. Kwe, a Cameroonian national, served as his research fellow, and both foreign nationals enjoyed full access to one of the most sensitive research installations operated by the U.S. government, yet, according to federal prosecutors, both allegedly decided that the rules governing such material did not apply to them.
The Montana lab was already under intense scrutiny before the criminal complaint surfaced. Just a week earlier, Sen. Tim Sheehy (R-MT) had formally requested that the Department of Health and Human Services Inspector General investigate the facility after a lab worker was bitten by a monkey infected with Crimean-Congo hemorrhagic fever, and Sheehy also highlighted a whistleblower complaint targeting Munster personally, a complaint first brought forward by White Coat Waste, a conservative animal-rights watchdog group.
Conservative activist Laura Loomer had likewise been publicly sounding the alarm, calling for federal intervention against both the lab and Munster himself. Those warnings, once dismissed by some as alarmist, now look prescient in light of the FBIs findings and the Justice Departments decision to bring charges.
Federal investigators have so far tested only a fraction of the seized material, examining 20 of the 113 vials. Of those, 17 contained deactivated mpox, one contained the virus that causes chickenpox, and two held human DNA, leaving 93 vials still untested and their precise contents not yet publicly disclosed.
Some observers may be tempted to downplay the incident on the grounds that the mpox samples were deactivated, meaning they could no longer replicate or infect cells. Prosecutors are not alleging that passengers on the flight were in immediate danger, but they are emphasizing that the core offense lies in the decision to remove regulated biological material from an active outbreak zone, conceal it in a black case, transport it on a crowded commercial airliner, lie to federal agents about its nature, and do so without any of the required permits.
Federal law does not grant a free pass simply because the contraband is inert, and the U.S. Attorneys Office made that point unmistakably clear. U.S. Attorney Jerome Gorgon Jr. stated in a press release, "These NIH experts apparently broke our laws by smuggling viral pathogens on a packed commercial airplane from an outbreak in the Republic of Congo. Let that sink in."
The FBI echoed that message, underscoring that scientific credentials do not confer immunity from the law. FBI Special Agent in Charge Jennifer Runyan said: "No researchers should believe their positions, credentials, or professional status place them above the law."
Customs and Border Protection officials were equally blunt about the broader implications for national security and public safety. CBP Director of Field Operations Marty C. Raybon added: "We have zero tolerance for anyone who attempts to exploit our research frameworks, circumvent our border enforcement processes, or deceive investigators. We will remain fiercely vigilant in neutralizing biological threats and continue to hold accountable those who jeopardize the safety and security of the American people."
Munster and Kwe now face charges of conspiracy to smuggle goods contrary to law and making false statements to federal agents, with each count carrying a maximum penalty of five years in federal prison. The case underscores how even elite government laboratories can become flashpoints for misconduct that potentially endangers the public and undermines trust in taxpayer-funded science.
This episode is not an isolated aberration in the same federal judicial district. In November 2025, a Chinese national working at a University of Michigan laboratory pleaded guilty and was sentenced for smuggling a dangerous biological pathogen into the United States, a strikingly similar category of offense that suggests a troubling pattern rather than a one-off lapse.
After CBP flagged the Detroit incident in January, NIH insists it acted swiftly behind the scenes. HHS press secretary Emily Hilliard told Politico the agency "immediately activated established agency protocols" once leadership was notified, securing lab spaces, restricting access, and conducting a full inventory audit, and NIH further asserted there was "no risk at any time to the staff or public" in or around the Hamilton facility.
That internal response may be technically reassuring, but it also highlights a glaring transparency problem. For five months, there was no public statement, no disclosure to the communities surrounding the lab, and no acknowledgment of the alleged smuggling until federal charges made silence untenable.
The criminal complaint does not explain why Munster and Kwe allegedly chose to move the samples in this manner. Perhaps the material was considered too valuable to leave behind, or perhaps this was not the first time such a transfer had occurred, but at this stage those possibilities remain speculative.
What is not in dispute is the basic sequence of events: two NIH researchers boarded a packed commercial flight from an active outbreak zone with 113 vials of biological material, misrepresented the contents to federal agents, and apparently counted on the assumption that no one would probe too deeply. Someone did.
The FBI, CBP, and the HHS Inspector General continue to investigate, and under the American system of justice, the charges remain allegations and both men are presumed innocent until proven guilty in court. Yet the larger questions now fall to Congress and oversight bodies: who else knew, how long did leadership sit on this information, and why are federally funded labsentrusted with dangerous pathogens and billions in public moneyrepeatedly at the center of smuggling cases that should never have been possible in the first place.
Login